Publication:
A primary extended cytoreductive surgery for ovarian cancer: total abdominal hysterectomy and bilateral salpingo-oophorectomy, total omentectomy, total peritonectomy, bilateral diaphragm stripping, cholecystectomy, total colectomy, splenectomy, bilateral pelvic-paraaortic lymphadenectomy, dissection of porta hepatis, liver metastasectomy, and bilateral cardiophrenic lymphadenectomy

dc.contributor.coauthorGiray, B.
dc.contributor.coauthorKumcular, T.
dc.contributor.coauthorArvas, M.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorBalık, Emre
dc.contributor.kuauthorMısırlıoğlu, Selim
dc.contributor.kuauthorTaşkıran, Çağatay
dc.contributor.kuauthorVatansever, Doğan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:51:54Z
dc.date.issued2019
dc.description.abstractIntroduction/Background: Ovarian cancer is the leading cause of death among gynecological malignancies. Primary cytoreduction for ovarian cancer is associated with significantly improved survival. We aimed to present a primary extended cytoreduction performed in this video. Methodology: A 37 years-old woman was admitted with abdominal swelling and pelvic pain. Pelvic examination revealed out ascites and bilateral adnexal masses. MRI showed 11-cm right adnexal mass, 7-cm left adnexal mass, omental cakes, disseminated peritoneal implants, liver metastases, and enlarged lymph nodes in the right obturator fossa. Total abdominal hysterectomy, bilateral salpingo-oophorectomy, total omentectomy, total peritonectomy, bilateral diaphragmatic stripping, total colectomy, splenectomy, bilateral pelvic-paraaortic lymphadenectomy, cholecystectomy, dissection of the porta hepatis, liver metastasectomy, and transabdominal cardiophrenic lymph node dissection were performed as a part of maximal primarily cytoreduction. Results: We did not encounter any grade 3 or 4 adverse event in post-operative period. Conclusion: Primary cytoreduction for ovarian cancer with no residual disease is a major impact on survival. The management of this condition should be performed with expert multidisciplinary teams in gynecological oncology.
dc.description.indexedbyWOS
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume29
dc.identifier.doi10.1136/ijgc-2019-ESGO.1341
dc.identifier.eissn1525-1438
dc.identifier.issn1048-891X
dc.identifier.quartileQ1
dc.identifier.urihttps://doi.org/10.1136/ijgc-2019-ESGO.1341
dc.identifier.urihttps://hdl.handle.net/20.500.14288/14775
dc.identifier.wos523502503318
dc.language.isoeng
dc.publisherBmj Publishing Group
dc.relation.ispartofInternational Journal of Gynecological Cancer
dc.subjectOncology
dc.subjectObstetrics
dc.subjectGynecology
dc.titleA primary extended cytoreductive surgery for ovarian cancer: total abdominal hysterectomy and bilateral salpingo-oophorectomy, total omentectomy, total peritonectomy, bilateral diaphragm stripping, cholecystectomy, total colectomy, splenectomy, bilateral pelvic-paraaortic lymphadenectomy, dissection of porta hepatis, liver metastasectomy, and bilateral cardiophrenic lymphadenectomy
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorTaşkıran, Çağatay
local.contributor.kuauthorVatansever, Doğan
local.contributor.kuauthorMısırlıoğlu, Selim
local.contributor.kuauthorEraslan, A.
local.contributor.kuauthorBalık, Emre
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files